Allergan Aesthetics Releases 'The Aesthetics Evolution: What Consumers Really Want' Highlighting Consumer Motivations and Expectations in Aesthetics

Rhea-AI Summary

Allergan Aesthetics (NYSE:ABBV) released “What Consumers Really Want”, the latest report in The Aesthetics Evolution series, profiling today’s aesthetics consumers and their expectations from personalized, end-to-end aesthetic experiences.

The report highlights themes on spending priorities, desire for natural results, value of in-depth consultations, trust in providers, and proactive approaches to aging.

AI-generated analysis. How Rhea-AI works. Not financial advice.

News Market Reaction – ABBV

-0.21%

-0.21% News Effect

On the day this news was published, ABBV declined 0.21%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Report says that younger adult consumers say satisfaction with their appearance impacts their mental (62%) and physical (53%) well-being.¹

IRVINE, Calif., June 10, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, today announced the release of What Consumers Really Want, the latest installment in The Aesthetics Evolution series. On the heels of The Hyaluronic Injectable Fillers Report, this report profiles today's aesthetics consumers, how their views on aesthetics are shaped and shifting, and what they expect from a personalized, end-to-end aesthetic experience.

"Aesthetics is no longer transactional, it's transformational," said Nicole Mowad-Nassar, Senior Vice President, AbbVie and President, Global Allergan Aesthetics. "Understanding the consumer landscape and consumer mindset is what drives Allergan Aesthetics' commitment to advancing innovation, education, and leadership across the industry. Our latest report shows that consumers are taking a more positive and proactive approach to aging. It is our job to understand and deliver on that new perspective."

What Consumers Really Want Key Themes and Insights
What Consumers Really Want expands on evolving consumer attitudes and expectations in aesthetics through several key themes:

• All-In on Aesthetics: Introduces today's aesthetics consumers including priorities, spending habits and attitudes about aesthetics.
  • 53% of consumers would reduce their luxury spending to afford aesthetic treatments.²
• Natural Attraction: Dives into the changing perspective on aging, the emotional benefits of aesthetics treatments and the increased value of individualized results.
  • 75% of HCPs report that patients want to look natural.³
• Consultation is Connection: Explores the value of in-depth consultations when introducing new patients to aesthetics and creating a path for their journey ahead.
  • 65% of patients who have multiple full-face consultations treat three or more facial areas, compared to just 23% after a single visit.⁴
• Trust the Plan: Examines the relationship between patient and providers and the role trust plays in building the desired all-encompassing holistic approach to aging.
  • The #1 reason patients rank as returning to a previous cosmetic injector is "trust in my practitioner's action and ability" - above cost and convenience.⁵
• Delivering the Future: Looks at the increasing demand for optimal results for the proactive patients of today and tomorrow.

The report delivers insights from Allergan Aesthetics' consumer market research, healthcare provider (HCP) data and expert perspectives. Report insights were further validated through interviews with leading aesthetics practitioners from key U.S. markets, including Catherine Chang, MD (Beverly Hills, CA), Shawna Chrisman, NP (Sacramento, CA), Steven Dayan, MD (Chicago, IL), Evan Rieder, MD (New York, NY), and Anthony Rossi, MD (New York, NY).

The Aesthetics Evolution: The Hyaluronic Acid (HA) Injectable Fillers Report 
The Aesthetics Evolution Series continues to set the standard for what is now and next in aesthetics. The inaugural report, The Hyaluronic Acid (HA) Injectable Fillers Report, challenged common misconceptions about fillers, explored the science behind natural-looking results, and provided a deeper understanding of modern aesthetic expectations. These report series deliver a clear, authoritative view of the market and help drive industry conversation, define trends, and deliver actionable insights.

To access the new report and learn more about The Aesthetics Evolution series, including The Hyaluronic Acid (HA) Injectable Fillers Report, please visit www.theaestheticsevolution.com.

About Allergan Aesthetics 
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com. 

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube. 

U.S. Media:
Kate McShane, Corporate Communications
Kate.mcshane@allergan.com

References

1. Allergan Aesthetics 2025 Psychology of Aging – Evaluation of Younger and Older Ages (20 – 80 Years): Quantitative Research for U.S.
2. Allergan Aesthetics 2024 Share of Wallet Assessment – Prioritization of Aesthetic Treatments: Quantitative Research with Consumers.
3. Allergan Aesthetics 2024 What is Natural – HCP Report: Qualitative Research.
4. Allergan Aesthetics 2025 Filler Consumer A&U.
5. Aesthetic Surgery Journal, Volume 4. The Importance of Functional Quality in Patient Satisfaction: Cosmetic Injectable Patient Experience Exploratory Study—Part 2, Cara B McDonald and Izolda Heydenrych, 2022 https://doi.org/10.1093/asjof/ojac044.

View original content to download multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-releases-the-aesthetics-evolution-what-consumers-really-want-highlighting-consumer-motivations-and-expectations-in-aesthetics-302795767.html

SOURCE AbbVie

FAQ

What is Allergan Aesthetics’ “What Consumers Really Want” report for ABBV investors?

The report is a market insight study on aesthetics consumers’ motivations and expectations. According to Allergan Aesthetics, it outlines key themes like spending priorities, natural-looking results, consultation value, and trust, helping investors understand evolving demand drivers in the aesthetics market.

What key consumer spending trend does the Allergan Aesthetics report highlight for ABBV?

The report indicates many consumers prioritize aesthetics over other discretionary spending. According to Allergan Aesthetics, 53% of consumers would reduce luxury spending to afford aesthetic treatments, signaling resilient demand patterns that may be relevant for AbbVie’s aesthetics portfolio.

How do patients feel about natural-looking results in Allergan Aesthetics’ 2026 report?

Patients widely prefer natural-looking aesthetic outcomes. According to Allergan Aesthetics, 75% of healthcare providers report that patients want to look natural, underscoring the importance of individualized treatment plans and technologies that support subtle, personalized results for aesthetics-focused healthcare companies like AbbVie.

What does the Allergan Aesthetics report say about consultations and treatment uptake?

The report links deeper consultations to broader treatment adoption. According to Allergan Aesthetics, 65% of patients with multiple full-face consultations treat three or more facial areas, compared with 23% after a single visit, highlighting the commercial importance of comprehensive patient engagement.

How does trust influence repeat aesthetics visits in Allergan Aesthetics’ findings?

Trust is identified as the top driver of return visits to cosmetic injectors. According to Allergan Aesthetics, patients rank “trust in my practitioner’s action and ability” as the number-one reason for returning, placing it above both cost and convenience in importance.

How does “What Consumers Really Want” fit into The Aesthetics Evolution series?

The report is the latest installment in The Aesthetics Evolution series. According to Allergan Aesthetics, it follows The Hyaluronic Acid Injectable Fillers Report and continues to define trends, challenge misconceptions, and provide actionable insights on current and emerging aesthetics market dynamics.